NEUROBALANCE training to improve balance after traumatic brain injury
Official title: Neuromodulation-Enhanced Use of RObotic Balance Training to Improve Postural Control in Individuals With Traumatic Brain Injury
Run by Kessler Foundation · NCT06584591 · Data updated 2026-11-12
This study will test whether combining robotic balance training with noninvasive brain stimulation helps adults with chronic traumatic brain injury who still have balance problems.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 45 (estimated) |
| Sponsor | Kessler Foundation Academic / other |
| Locations | 1 site (West Orange, New Jersey) |
| Status | Recruiting |
| Started | August 1, 2025 |
| Main results expected | August 2027 |
| Study ends | December 2027 |
| Registry record updated | August 6, 2025 |
| Trial ID | NCT06584591 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults 18–75 with a non‑penetrating TBI at least six months earlier who have persistent balance complaints (e.g., Berg Balance Scale ≤50), can stand for ≥20 seconds and walk ≥10 meters, and can follow study instructions.
✕Probably not a fit
People with penetrating TBI or recent stroke, current participation in regular balance physical therapy, significant peripheral neuromuscular or orthopedic lower‑limb problems, persistent pain limiting participation, or inability to consent/comply are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized study will enroll 45 adults with non‑penetrating traumatic brain injury at least six months after injury and persistent balance deficits. Participants will be randomized to robotic balance training plus active HD‑tDCS, robotic balance training plus sham stimulation, or standard-of-care balance rehabilitation. The intervention consists of 12 training sessions over four weeks using the Hunova robotic platform, with assessments at baseline, immediately post-training, and two months later to measure balance outcomes, brain and muscle activity, and retention. Study outcomes include clinical balance measures, laboratory measures of postural control, and neurophysiologic markers.
Why it matters
Potential benefit: If successful, the approach could produce longer-lasting improvements in balance and reduce fall risk, improving daily function for people with chronic TBI.
How similar studies have gone: Previous studies of robotic balance devices and of tDCS separately have shown promising but mixed short‑term improvements, while combining HD‑tDCS with the Hunova platform represents a relatively novel, less-tested approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Aged between 18-75 years 2. Diagnosed with a non-penetrating TBI at least six months before the screening. 3. Have complaints of impaired balance and poor postural control determined by a BBS score of ≤50. 4. Ability to stand upright with or without support for at least 20 seconds 5. Ability to walk with or without a walking aid for at least ten meters 6. Not planning to change medication in the next four months 7. Minimum Cognitive Ability to understand the verbal instructions and comply with the study procedures, as determined by the University of California, San Diego, Brief Assessment of Capacity to Consent Instrument (UBACC). Exclusion Criteria: 1. Currently undergoing any regular physical therapy program or research studies focusing on balance functions. 2. Having a stroke or a penetrating TBI. 3. Affected by the peripheral nerve injury, neuromuscular conditions, or orthopedic issues of lower limbs before TBI, or have any persistent pain or difficulty maintaining blood pressure while upright. 4. Have a scalp or skin condition (e.g., psoriasis or eczema) on the scalp near the stimulation site. 5. Severe visual impairment (e.g., spatial neglect) or hearing problems may affect study compliance. 6. Any other neurological injury or psychiatric conditions (e.g., severe anxiety or schizophrenia, etc.) 7. Not being pregnant or thinking of becoming pregnant during the study period. 8. Diagnosed with alcohol or substance abuse in the last three years. 9. Contraindications to TMS, including the presence of metallic implants in the head and history of seizures or medication-resistant epilepsy.
Where it's running
-
Kessler Foundation
West Orange, New Jersey, United States Recruiting
Study contacts
- Principal investigator: Vikram Shenoy Handiru, Ph.D. — Kessler Foundation
- Study coordinator: Vikram Shenoy Handiru, Ph.D.
- Email: vshenoy@kesslerfoundation.org
- Phone: 9733243578
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
PIONEER-Prognosis: Using biomarkers and wearables to forecast recovery after mild traumatic brain injury
This study tests whether blood biomarkers, health data from records, and wearables can help predict how people recover after a mild traumatic brain injury treated in the emergency department.
-
HBOT to see if it helps cognition and well‑being in first responders with prior brain injury
This study tests whether 40 hyperbaric oxygen therapy sessions can improve thinking skills and post-concussion symptoms in current or former first responders with a history of brain injury.
-
Depth Electrode Monitoring after Traumatic Brain Injury
This study tests adding a depth electrode with continuous brain monitoring during external ventricular drain placement in adults with traumatic brain injury to see if cortical reverberation signals can be tracked safely.
-
Neurofeedback and tRNS for Attention After Brain Injury
This study tests whether neurofeedback combined with transcranial random noise stimulation can help adults with attention problems after brain injury.
-
Understanding growth hormone deficiency after a brain injury in adults
This observational study tests whether growth hormone deficiency affects quality of life and symptoms in adults with traumatic brain injury and whether GH replacement helps after 12 weeks.
-
Hyperacute Neurobiomarker Kinetics in Acute Brain Injury: What Happens in Minutes After Injury
This study tests how early brain injury biomarkers behave in the first minutes to hours after traumatic brain injury or cardiac arrest to see if they rise quickly enough to help with early care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.